New York State Common Retirement Fund’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

New York State Common Retirement Fund’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28,231	Closed	-$3.03M	–	3470
2023 Q1	$3.03M	Sell	28,231 -8,762	-24%	-$1.01M	﹤0.01%	1368
2022 Q4	$4.07M	Sell	36,993 -5,790	-14%	-$375K	0.01%	1272
2022 Q3	$2.52M	Buy	42,783 +5,622	+15%	+$257K	﹤0.01%	1488
2022 Q2	$1.05M	Buy	37,161 +4,973	+15%	+$144K	﹤0.01%	1990
2022 Q1	$1.22M	Buy	32,188 +14,489	+82%	+$573K	﹤0.01%	2006
2021 Q4	$700K	Buy	17,699 +7,882	+80%	+$247K	﹤0.01%	2261
2021 Q3	$233K	Buy	9,817 +117	+1%	+$2.76K	﹤0.01%	2859
2021 Q2	$238K	Buy	+9,700	New	+$216K	﹤0.01%	2972

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

New York State Common Retirement Fund's RXDX Position: Q2 2023 in Review

New York State Common Retirement Fund sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 28,231 shares — an estimated $3.03M sold.

New York State Common Retirement Fund first reported a position in RXDX in Q2 2021 and held it in 8 quarters. The position peaked at $4.07M in Q4 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

New York State Common Retirement Fund reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
New York State Common Retirement Fund sold 28,231 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $3.03M.
New York State Common Retirement Fund first reported a position in Prometheus Biosciences, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
New York State Common Retirement Fund's Prometheus Biosciences, Inc. Common Stock position peaked at $4.07M in Q4 2022.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on New York State Common Retirement Fund's 13F filing for Q2 2023, filed 7 Aug 2023.